Drugs, alcohol, pregnancy, and the fetal alcohol syndrome

International Anesthesiology Clinics

Volumn 49, Issue 1, 2011, Pages 119-133

  Frost, Elizabeth A M ^a   Gist, Richard S ^b   Adriano, Elizabeth ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; COCAINE; FLUMAZENIL; LORAZEPAM; METHAMPHETAMINE; MIDAZOLAM; OPIATE;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ANESTHESIA; ARTICLE; CIGARETTE SMOKING; CLINICAL FEATURE; DRUG ABUSE; FETAL ALCOHOL SYNDROME; HUMAN; INCIDENCE; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ALCOHOLISM; ANESTHESIA; FEMALE; FETAL ALCOHOL SYNDROME; FETUS; HUMANS; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 78751612691     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/AIA.0b013e3181ff4dd0     Document Type: Article

References (61)

1. Keegan J, Parva M, Finnegan M, et al. Addiction in pregnancy. J Addict Dis. 2010;29:175-191.
2. National Survey on Drug Use and Health. Substance use during pregnancy: 2002 and 2003 update.www.oas.samhsa.gov/2k5/pregnancy/pregnancy.htm (Accessed 3 July 2010).
3. Kilmer G, Roberts H, Hughes E, et al. Surveillance of certain health behaviors and conditions among states and selected local areas\Behavioral Risk Factor Surveillance System (BRFSS), United States, 2006. MMWR Surveill Summ. 2008;57: 1-188.
4. Bush B, Shaw S, Cleary P, et al. Screening for alcohol abuse using the CAGE questionnaire. Am J Med. 1987;82:231-235.
5. Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84:1353-1357.
6. Hodges B, Mazur JE. Intravenous ethanol for the treatment ofalcohol withdrawal in critically ill patients. Pharmacotherapy. 2004;24:1578-1585.
7. Jones KL, Smith DW. Recognition offetal alcohol syndrome in early infancy. Lancet. 1973;1:1267-1271.
8. Sullivan WC A note on the influence ofmaternal inebriety on the offspring. J Ment Sci. 1899;45:489-503.
9. Goddard HH. The Kallikak Family: A Study in the Heredity of Feeble-Mindedness. New York: Macmillan; 1912.
10. Karp RJ, Qazi QH, Moller KA, et al. Fetal alcohol syndrome at the turn of the century: an unexpected explanation of the Kallikak family. Arch Pediatr Adolescent Med. 1995;149:45-48.
11. Lemoine P, Harousseau H, Borteyru JP, et al. Les enfants de parents alcoholique: anomalies observees. Quest Med. 1968;25:476-482.
12. Ulleland CN. The offspring of alcoholic mothers. Ann N Y Acad Sci. 1972;197: 167-169.
13. Olegard R, Sabel KG, Aronsson M, et al. Effects on the child ofalcohol abuse during pregnancy. Acta Paediatr Scand. 1979;275:112-121.
14. Jones KL, Smith DW, Ulleland CN, et al. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet. 1973;1:1267-1271.
15. Streissguth AP. History offetal alcohol syndrome. In: Streissguth A, Kanter J, eds. The Challenge in Fetal Alcohol Syndrome: Overcoming Secondary Disabilities. Seattle: University ofWA Press; 2002.
16. Hanson JW, Jones KL, Smith DW. Fetal alcohol syndrome: experience with 41 patients. JAMA. 1976;235:1450-1460.
17. Clarren SK, Smith DW. The fetal alcohol syndrome. N Engl J Med. 1978;19: 1063-1067.
18. Majewski F, Bierich JR, Michaelis R. Diagnose: alkoholembryopathie. Dtsch Arztebl. 1977;17:1133-1136.
19. Abel EL, Sokol RJ. Incidence offetal alcohol syndrome and economic impact of FAS-related anomalies: Drug alcohol syndrome and economic impact of FAS-related anomalies. Drug Alcohol Depend. 1987;19:51-70.
20. Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis (PDF). CDC (July 2004).
21. Day NL. The effects of prenatal exposure to alcohol. Alcohol Health Res World. 1992;16:328-344.
22. Goodlett CR, Peterson SD. Sex differences in vulnerability to developmental spatial learning deficits induced by limited binge alcohol exposure in neonatal rats. Neurobiol Learn Memory. 1995;64:265-275.
23. Streissguth AP, Barr HM, Sampson PD, et al. Prenatal alcohol and offspring development: the first fourteen years. Drug Alcohol Depend. 1994;36:89-99.
24. Wilkie S. Global overview of drinking recommendations and guidelines. AIM Digest (Supplement). 1997;2-4:4.
25. Abel E. Moderate drinking during pregnancy: cause for concern? Clin Chim Acta. 1996;246:149-154.
26. Forrest F, du Florey C. Reported social alcohol consumption during pregnancy and infants' development at 18 months. Br MedJ. 1991;303:22-26
27. du Florey D, Taylor D, Bolumar F, et al. A European concerted action: maternal alcohol consumption and its relation to the outcome of pregnancy and development at 18 months. IntJ Epidemiol. 1992;21(suppl 1):s38-s39.
28. Polygenis D, Wharton S, Malmberg C, et al. Moderate alcohol consumption during pregnancy and the incidence of fetal malformations: a meta-analysis. Neurotoxicol Teralol. 1998;20:61-67.
29. Hanson JW, Streissguth AP, Smith DW. The effects of moderate alcohol consumption during preganant on fetal growth and morphogenesis. J Pediatr. 1978;92:457-460.
30. Mills JL, Graubard BI. Is moderate drinking during pregnancy associated with an increased risk for malformations? Pediatrics. 1987;80:309-314.
31. Strandberg-Larsen K, Granboek M, Andersen AM, et al. Alcohol drinkiing during pregnancy and risk of infant mortality. Epidemiology. 2009;20:884-891.
32. Ernhart CB, Sokol RJ, Martier S, et al. Alcohol teratogenicity in the human: a detailed assessment of specificity, critical period and threshold. AmJ Obstet Gynecol. 1987;156: 33-39.
33. Kolke M. Cytogenetic effects of maternal alcohol uptake on Fsub 1 mouse fetuses. Jpn J Hyg. 1985;40:575-585.
34. Gardner LI, Mitter N, Copplan J, et al. Isochromosome 9q in an infant exposed to ethanol prenatally. N Engl J Med. 1985;312:1521.
35. Bingol N, Fuchs M, Iosub S, et al. Fetal alcohol syndrome associated with trisomy 21. Alcohol Clin Exp Res. 1987;11:42-44.
36. Idanpaan-Herkkila J, Jouppila P, Akerblom HK, et al. Elimination and metabolic effects ofethanol in mother, fetus and newborn infant. AmJ Obstet Gynecol. 1972;112: 387-393.
37. Halmesmaki E, Autti I, Granstrom ML, et al. Alpha-fetoprotein, human placental lactogen and pregnancy-specific beta-glycoprotein in pregant women who drink: relation to fetal alcohol syndrome. Am J Obstet Gynecol. 1986;155:598-601.
38. Smith DW. The fetal alcohol syndrome. Hosp Pract. 1979;14:121-128.
39. Pierog S, Chandavaasu O, Wexler I. Withdrawal symptoms in infants with FAS. J Pediatr. 1977;90:630-633.
40. Stromland K. Ocular involvement in the fetal alcohol syndrome. Surv Ophthalmol. 1987;31:277-284.
41. Sandor G, Smith DW, MacLeod PM. Cardiac malformations in eth fetal alcohol syndrome. J Pediatr. 1981;98:771-773.
42. Douglas TS, Mutsvangwa TE. A review offacial image analysis for delineation of the facial phenotype associated with fetal alcohol syndrome. Am J Med Genet A. 2010; 152A:528-536.
43. Banakar MK, Kudlur NS, George S. Fetal alcohol spectrum disorder (FASD). Indian J Pediatr. 2009;76:1173-1175.
44. Mizejewski GJ. Can prenatal screening for fetal alcohol spectrum disorder be justified? A commentary. Gynecol Obstet Invest. 2009;69:128-130.
45. Morojele NK, London L, Olorunju SA, et al. Predoictors of risk of alcohol-exposed pregancies among women in an urban and a rural area of South Africa. Soc Sci Med. 2010;70:534-542.
46. May PA, Gossage JP, Marais LS, et al. Maternal risk factors for fetal alcohol syndrome and partial fetal alcohol syndrome in South Africa: a third study. Alcohol Clin Exp Res. 2008;32:738-753.
47. Bada HS, Das A, Bauer CR, et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol. 2002;100(5 Pt 1):916-924.
48. Bandstra ES, Morrow CE, Anthony JC, et al. Intrauterine growth of full-term infants: impact ofprenatal cocaine exposure. Pediatrics. 2001;108:1309-1319.
49. Gilloteaux J, Ekwedike NN. Cocaine causes atrial Purkinje fiber damage. Ultrastruct Pathol. 2010;34:90-98.
50. Pinto SM, Dodd S, Walkinshaw SA, et al. Substance abuse during pregnancy: effect on pregnancy outcomes Eir. J Gynecol Reprod Biol. 2010;150:137-141.
51. Krzysztof M. The effects of drug abuse on pregnancy. Current Opinion in Obstetrics and Gynecology. 2007;19:578-585.
52. Hollander JE, Hoffman RS. Cocaine. In: Goldfrank LR, Flowenbaum N, Lewin M, et al, eds. Goldfrank's Toxicologic Emergencies. 7th ed. McGraw Hill Medical Publishing: New York; 2002.
53. Smith LM, Lagasse LL, Derauf C, et al. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol. 2008;30:20-28. Epub 2007 Oct 3.
54. Dattel BJ. Substance abuse in pregnancy. Semin Perinatol. 1990;14:179-187.
55. Kandall SR, Doberczak TM, Jantunen M, et al. The methadone-maintained pregnancy. Clin Perinatol. 1999;26:173-183.
56. Dashe JS, Jackson GL, Olscher DA, et al. Opioid detoxification in pregnancy. Obstet Gynecol. 1998;92:854-858.
57. Lacroix I, Berrebi A, Chaumerliac C, et al. Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction. 2004;99:209-214.
58. Lejeune C, Simmat-Durand L, Gourarier L, et al. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution. Drug Alcohol Depend. 2006;82: 250-257.
59. Campolongo P, Trezza V, Ratano P, et al. Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychpharmacology (Berl). 2010 June 17. [Epub ahead of print].
60. Gentile S. On categorizing gestational, birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome. CNS Spectr. 2010;15:167-185.
61. Gentile S. Serotonin reuptake inhibitor-induced perinatal complications. Paediatr Drugs. 2007;9:97-102.